EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 95 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $865 | +3.8% | 151,000 | +40.5% | 0.00% | 0.0% |
Q2 2023 | $833 | +28.9% | 107,500 | +11.1% | 0.00% | 0.0% |
Q1 2023 | $646 | -6.9% | 96,800 | +24.7% | 0.00% | 0.0% |
Q4 2022 | $694 | -99.9% | 77,600 | +33.1% | 0.00% | 0.0% |
Q3 2022 | $574,000 | +121.6% | 58,300 | +78.8% | 0.00% | – |
Q2 2022 | $259,000 | – | 32,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |